Auro Laboratories Limited (BOM:530233)
India · Delayed Price · Currency is INR 298.65
-0.90 (-0.30%)
At close: Feb 12, 2026
Auro Laboratories Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Operating Revenue | - | 193.98 | 536.35 | 528.94 | 508.66 | 542.52 |
| 284.46 | 193.98 | 536.35 | 528.94 | 508.66 | 542.52 | |
Revenue Growth (YoY) | 18.92% | -63.83% | 1.40% | 3.99% | -6.24% | 23.89% |
Cost of Revenue | 92.29 | 92.82 | 269.49 | 360.69 | 335.46 | 293.28 |
Gross Profit | 192.17 | 101.16 | 266.86 | 168.26 | 173.19 | 249.24 |
Selling, General & Admin | 41.88 | 24.68 | 51.44 | 47.21 | 62.4 | 60.37 |
Other Operating Expenses | 74.19 | 42.46 | 108.72 | 77.12 | 64.54 | 76.46 |
Operating Expenses | 137.99 | 78.09 | 171.09 | 135.07 | 137.12 | 147.18 |
Operating Income | 54.17 | 23.07 | 95.78 | 33.19 | 36.08 | 102.06 |
Interest Expense | -29.89 | -10.01 | -6.69 | -7.3 | -5.49 | -3.12 |
Interest & Investment Income | 0.72 | 0.72 | 0.67 | 1.05 | 3.51 | 1.8 |
Currency Exchange Gain (Loss) | 5.77 | 5.77 | 14.32 | 8.36 | 6.95 | 5.74 |
Other Non Operating Income (Expenses) | 6.03 | -0.74 | -0.61 | -0.84 | -2.78 | -1.44 |
EBT Excluding Unusual Items | 36.81 | 18.81 | 103.46 | 34.46 | 38.28 | 105.05 |
Pretax Income | 36.81 | 18.81 | 103.46 | 34.46 | 38.74 | 105.05 |
Income Tax Expense | 4.42 | 0.42 | 25.54 | 10.04 | 10.29 | 33.25 |
Net Income | 32.39 | 18.39 | 77.92 | 24.42 | 28.45 | 71.8 |
Net Income to Common | 32.39 | 18.39 | 77.92 | 24.42 | 28.45 | 71.8 |
Net Income Growth | -8.61% | -76.40% | 219.09% | -14.15% | -60.38% | 77.08% |
Shares Outstanding (Basic) | 6 | 6 | 6 | 6 | 6 | 6 |
Shares Outstanding (Diluted) | 6 | 6 | 6 | 6 | 6 | 6 |
Shares Change (YoY) | -8.58% | - | - | - | - | - |
EPS (Basic) | 5.20 | 2.95 | 12.50 | 3.92 | 4.56 | 11.52 |
EPS (Diluted) | 5.20 | 2.95 | 12.50 | 3.92 | 4.56 | 11.52 |
EPS Growth | -0.00% | -76.40% | 219.03% | -14.07% | -60.41% | 77.08% |
Free Cash Flow | - | -180.54 | -168.33 | -7.93 | -112 | 124.41 |
Free Cash Flow Per Share | - | -28.97 | -27.01 | -1.27 | -17.97 | 19.96 |
Gross Margin | 67.55% | 52.15% | 49.76% | 31.81% | 34.05% | 45.94% |
Operating Margin | 19.04% | 11.89% | 17.86% | 6.27% | 7.09% | 18.81% |
Profit Margin | 11.39% | 9.48% | 14.53% | 4.62% | 5.59% | 13.23% |
Free Cash Flow Margin | - | -93.07% | -31.39% | -1.50% | -22.02% | 22.93% |
EBITDA | 65.16 | 34.03 | 106.7 | 43.93 | 46.25 | 112.42 |
EBITDA Margin | 22.91% | 17.54% | 19.89% | 8.30% | 9.09% | 20.72% |
D&A For EBITDA | 10.99 | 10.96 | 10.92 | 10.74 | 10.17 | 10.36 |
EBIT | 54.17 | 23.07 | 95.78 | 33.19 | 36.08 | 102.06 |
EBIT Margin | 19.04% | 11.89% | 17.86% | 6.27% | 7.09% | 18.81% |
Effective Tax Rate | 12.01% | 2.24% | 24.68% | 29.13% | 26.57% | 31.65% |
Revenue as Reported | 297.79 | 200.54 | 551.39 | 538.36 | 519.58 | 550.1 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.